Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXA2R | P21731 | 2/20 | 0.39 |
| ▸ | PTGFR | P43088 | 4/20 | 0.35 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.34 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NAMPT | P43490 | 1/20 | 0.31 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | SLCO2A1 | Q92959 | 1/20 | 0.31 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.31 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18532430 | 0.80 | PTGER3 (0.41) | PTGFRPTGER3ABCB11AKR1C3PTGER1 | |
| SCHEMBL24225469 | 0.73 | FDFT1 (0.40) | MEN1KMT2A | |
| SCHEMBL11782273 | 0.71 | PTGFR (0.39) | PTGFRPTGER3SLC18A3NAMPTABCB11 | |
| SCHEMBL11814870 | 0.71 | PTGFR (0.39) | PTGFRPTGER3SLC18A3NAMPTABCB11 | |
| SCHEMBL11814880 | 0.71 | PTGFR (0.39) | PTGFRPTGER3SLC18A3NAMPTABCB11 | |
| SCHEMBL19019689 | 0.70 | MFN2 (0.40) | PTGFRPTGER3SLC18A3MEN1KMT2A | |
| SCHEMBL20664824 | 0.68 | PTGFR (0.38) | PTGFRPTGER3KMT2AABCB11PTGER2 | |
| SCHEMBL18409970 | 0.67 | GRIN1 (0.43) | SLC18A3 | |
| SCHEMBL19020480 | 0.65 | EPHX2 (0.36) | — | |
| SCHEMBL19019688 | 0.65 | EPHX2 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2864308-B1 | (3aR,6aS)-2-Hydroxy-3,3a,6,6a-tetrahydro-2H-cyclopenta[b]furan-5-carbaldehyde intermediates for the preparation of prostaglandins or prostaglandin analogues | UNIV BRISTOL (GB) | 2016-10-19 | — | — | EP | disclosed |